Shrenik Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Shrenik.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Trade Distributors earnings growth	6.8%
Revenue growth rate	n/a
Future return on equity	n/a
Analyst coverage	None
Last updated	n/a

Recent future growth updates

No updates

Recent updates

Should You Be Worried About Shrenik Limited's (NSE:SHRENIK) 1.5% Return On Equity?

Mar 07

Here's Why Shrenik (NSE:SHRENIK) Is Weighed Down By Its Debt Load

Feb 15

Estimating The Intrinsic Value Of Shrenik Limited (NSE:SHRENIK)

Jan 28

Is Shrenik (NSE:SHRENIK) Likely To Turn Things Around?

Jan 11

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Shrenik has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

NSEI:SHRENIK - Analysts future estimates and past financials data (INR Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
9/30/2024	245	-2,351	N/A	N/A	N/A
6/30/2024	288	-616	N/A	N/A	N/A
3/31/2024	342	-2,355	208	208	N/A
12/31/2023	402	-34	N/A	N/A	N/A
9/30/2023	406	-28	N/A	N/A	N/A
6/30/2023	452	-481	N/A	N/A	N/A
3/31/2023	486	2	468	469	N/A
12/31/2022	482	-11	N/A	N/A	N/A
9/30/2022	461	-28	-94	-94	N/A
6/30/2022	417	-101	N/A	N/A	N/A
3/31/2022	638	-144	-77	-77	N/A
12/31/2021	1,356	-116	N/A	N/A	N/A
9/30/2021	1,721	-117	98	98	N/A
6/30/2021	3,390	-31	N/A	N/A	N/A
3/31/2021	3,637	-15	269	269	N/A
12/31/2020	4,198	11	N/A	N/A	N/A
9/30/2020	5,759	53	231	235	N/A
6/30/2020	6,250	61	N/A	N/A	N/A
3/31/2020	7,956	113	85	104	N/A
12/31/2019	8,771	140	N/A	N/A	N/A
9/30/2019	8,956	134	-369	-301	N/A
6/30/2019	8,683	120	N/A	N/A	N/A
3/31/2019	8,368	111	-247	-181	N/A
12/31/2018	7,743	94	N/A	N/A	N/A
9/30/2018	7,131	93	N/A	N/A	N/A
6/30/2018	6,532	86	N/A	N/A	N/A
3/31/2018	5,932	79	N/A	-469	N/A
3/31/2017	4,277	42	N/A	-131	N/A
3/31/2016	3,292	29	N/A	-75	N/A
3/31/2015	2,657	10	N/A	60	N/A
3/31/2014	2,131	10	N/A	-73	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if SHRENIK's forecast earnings growth is above the savings rate (6.7%).

Earnings vs Market: Insufficient data to determine if SHRENIK's earnings are forecast to grow faster than the Indian market

High Growth Earnings: Insufficient data to determine if SHRENIK's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if SHRENIK's revenue is forecast to grow faster than the Indian market.

High Growth Revenue: Insufficient data to determine if SHRENIK's revenue is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if SHRENIK's Return on Equity is forecast to be high in 3 years time

Shrenik Future Growth

Future criteria checks 0/6

Key information

Recent future growth updates

Recent updates

Chairman & MD recently sold ₹3.6m worth of stock

Chairman & MD recently sold ₹3.4m worth of stock

Chairman & MD recently sold ₹1.9m worth of stock

Chairman & MD recently sold ₹3.1m worth of stock

Second quarter 2025 earnings released

New major risk - Negative shareholders equity

Chairman & MD recently sold ₹1.8m worth of stock

Chairman & MD recently sold ₹244k worth of stock

Chairman & MD recently sold ₹769k worth of stock

Shrenik Limited, Annual General Meeting, Sep 30, 2024

Chairman & MD recently sold ₹313k worth of stock

First quarter 2025 earnings released

Chairman & MD recently sold ₹181k worth of stock

Chairman & MD recently sold ₹728k worth of stock

Insufficient new directors

Shrenik Limited Appoints Nirav Harshvadan Zaveri as Independent Director

Full year 2024 earnings released

Chairman & MD recently sold ₹6.5m worth of stock

Chairman & MD recently sold ₹295k worth of stock

Chairman & MD recently sold ₹1.1m worth of stock

Chairman & MD recently sold ₹542k worth of stock

Chairman & MD recently sold ₹207k worth of stock

Chairman & MD recently sold ₹543k worth of stock

Chairman & MD recently sold ₹544k worth of stock

Third quarter 2024 earnings released

Chairman & MD recently sold ₹626k worth of stock

Chairman & MD recently sold ₹370k worth of stock

Chairman & MD recently sold ₹1.0m worth of stock

Chairman & MD recently sold ₹1.7m worth of stock

Chairman & MD recently sold ₹973k worth of stock

Is Shrenik (NSE:SHRENIK) A Risky Investment?

Chairman & MD recently sold ₹935k worth of stock

First quarter 2024 earnings released: ₹0.77 loss per share (vs ₹0.01 profit in 1Q 2023)

Chairman & MD recently sold ₹1.3m worth of stock

Chairman & MD recently sold ₹1.2m worth of stock

Full year 2023 earnings released: EPS: ₹0.004 (vs ₹0.23 loss in FY 2022)

Chairman & MD recently sold ₹1.1m worth of stock

Is Shrenik (NSE:SHRENIK) Using Debt Sensibly?

Chairman & MD recently sold ₹108k worth of stock

Chairman & MD recently sold ₹2.4m worth of stock

Chairman & MD recently sold ₹2.5m worth of stock

Chairman & MD recently sold ₹1.6m worth of stock

Third quarter 2023 earnings released: EPS: ₹0.01 (vs ₹0.02 loss in 3Q 2022)

Is Shrenik (NSE:SHRENIK) A Risky Investment?

Chairman & MD recently sold ₹425k worth of stock

Chairman & MD recently sold ₹481k worth of stock

Chairman & MD recently sold ₹140k worth of stock

Chairman & MD recently sold ₹805k worth of stock

Second quarter 2023 earnings released: EPS: ₹0.03 (vs ₹0.09 loss in 2Q 2022)

Chairman & MD recently sold ₹519k worth of stock

Is Shrenik (NSE:SHRENIK) A Risky Investment?

Shrenik Limited, Annual General Meeting, Sep 29, 2022

Chairman & MD recently sold ₹774k worth of stock

Chairman & MD recently sold ₹957k worth of stock

Chairman & MD recently sold ₹1.2m worth of stock

First quarter 2023 earnings released: EPS: ₹0.01 (vs ₹0.06 loss in 1Q 2022)

Chairman & MD recently sold ₹190k worth of stock

Chairman & MD recently sold ₹335k worth of stock

Chairman & MD recently sold ₹233k worth of stock

Be Wary Of Shrenik (NSE:SHRENIK) And Its Returns On Capital

Full year 2022 earnings released: ₹0.23 loss per share (vs ₹0.024 loss in FY 2021)

Investors Could Be Concerned With Shrenik's (NSE:SHRENIK) Returns On Capital

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Chairman & MD recently sold ₹12m worth of stock

Shrenik (NSE:SHRENIK) Use Of Debt Could Be Considered Risky

Whole Time Director recently sold ₹9.9m worth of stock

Investors Could Be Concerned With Shrenik's (NSE:SHRENIK) Returns On Capital

Second quarter 2022 earnings released

Chairman & MD recently sold ₹3.6m worth of stock

Insider recently sold ₹782k worth of stock

Board Member recently sold ₹8.5m worth of stock

Does Shrenik (NSE:SHRENIK) Have A Healthy Balance Sheet?

First quarter 2022 earnings released: ₹0.06 loss per share (vs ₹0.03 loss in 1Q 2021)

Independent Director Manali Shah has left the company

Insider recently sold ₹744k worth of stock